bf/NASDAQ:SRPT_icon.jpeg

COM:SAREPTA

Sarepta Therapeutics

  • Stock

Last Close

120.42

08/11 21:00

Market Cap

14.11B

Beta: -

Volume Today

1.43M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
14.22M
-
9.76M
31.38%
1.25M
87.16%
5.42M
332.64%
154.58M
2,751.58%
301.03M
94.74%
380.83M
26.51%
540.10M
41.82%
701.89M
29.96%
933.01M
32.93%
1.24B
33.26%
cost of revenue
90.28M
-
130K
-
7.35M
5,556.15%
34.19M
365.02%
56.59M
65.49%
63.38M
12.01%
97.05M
53.12%
139.99M
44.25%
150.34M
7.40%
gross profit
-76.06M
-
9.76M
112.83%
1.25M
87.16%
5.29M
322.27%
147.23M
2,682.67%
266.84M
81.24%
324.25M
21.51%
476.72M
47.02%
604.84M
26.88%
793.02M
31.11%
1.09B
37.83%
selling and marketing expenses
2.55M
-
2.83M
11.15%
-2.22M
178.46%
general and administrative expenses
31.59M
-
49.31M
56.09%
75.04M
52.17%
81.20M
8.21%
119.85M
47.60%
209.98M
75.20%
284.81M
35.64%
317.88M
11.61%
282.66M
11.08%
451.42M
59.70%
481.87M
6.75%
selling general and administrative expenses
31.59M
-
49.31M
56.09%
75.04M
52.17%
83.75M
11.60%
122.68M
46.49%
207.76M
69.35%
284.81M
37.09%
317.88M
11.61%
282.66M
11.08%
451.42M
59.70%
481.87M
6.75%
research and development expenses
72.91M
-
94.23M
29.24%
146.39M
55.36%
188.27M
28.61%
166.71M
11.45%
401.84M
141.05%
560.91M
39.58%
722.34M
28.78%
771.18M
6.76%
877.09M
13.73%
877.39M
0.03%
other expenses
1.98M
-
-656K
133.10%
849K
229.42%
662K
22.03%
706K
6.65%
714K
1.13%
1.56M
118.35%
cost and expenses
104.50M
-
143.55M
37.36%
221.44M
54.26%
272.15M
22.90%
297.80M
9.42%
644.66M
116.48%
903.16M
40.10%
1.10B
22.27%
1.15B
4.29%
1.47B
27.58%
1.51B
2.85%
operating expenses
104.50M
-
143.55M
37.36%
221.44M
54.26%
272.02M
22.84%
290.44M
6.77%
610.47M
110.19%
846.57M
38.68%
1.04B
22.95%
1.05B
1.31%
1.33B
26.05%
1.36B
2.38%
interest expense
326K
-
-535K
-
5.78M
1,180.56%
33.71M
483.10%
30.67M
9.02%
59.95M
95.46%
63.52M
5.97%
53.25M
16.18%
22.01M
58.67%
ebitda
-68.26M
-
-131.01M
91.94%
-220.18M
68.07%
-266.73M
21.14%
-238.73M
10.50%
-342.76M
43.58%
-469.42M
36.95%
-529.28M
12.75%
-412.12M
22.14%
-473.54M
14.90%
-267.82M
43.44%
operating income
-90.28M
-
-133.79M
48.19%
-220.18M
64.58%
-266.73M
21.14%
-171.64M
35.65%
-343.63M
100.21%
-522.32M
52.00%
-564.16M
8.01%
-449.71M
20.29%
-536.20M
19.23%
-267.82M
50.05%
depreciation and amortization
1.28M
-
3.69M
188.96%
5.25M
42.20%
5.61M
6.94%
1.05M
81.23%
865K
17.85%
52.90M
6,015.49%
34.89M
34.05%
37.59M
7.75%
62.67M
66.70%
58.89M
6.02%
total other income expenses net
-22.03M
-
-2.78M
87.38%
154K
105.54%
-2.55M
1,754.55%
96.57M
3,890.15%
10.14M
89.50%
-191.56M
1,989.31%
11.10M
105.79%
30.76M
177.19%
-153.76M
599.84%
-252.27M
64.07%
income before tax
-111.98M
-
-135.79M
21.26%
-220.03M
62.04%
-267.26M
21.47%
-48.63M
81.81%
-362.61M
645.68%
-713.88M
96.87%
-553.07M
22.53%
-418.95M
24.25%
-689.96M
64.69%
-520.10M
24.62%
income tax expense
20.42M
-
-1.69M
108.27%
-5.25M
210.47%
-7.62M
45.30%
2.06M
127.02%
-692K
133.59%
1.20M
272.69%
1.06M
11.05%
-168K
115.80%
13.53M
8,150.60%
15.88M
17.40%
net income
-111.98M
-
-135.79M
21.26%
-220.03M
62.04%
-267.26M
21.47%
-50.69M
81.03%
-361.92M
614.01%
-715.08M
97.58%
-554.13M
22.51%
-418.78M
24.43%
-703.49M
67.99%
-535.98M
23.81%
weighted average shs out
33.83M
-
40.03M
18.31%
42.29M
5.66%
48.68M
15.12%
58.82M
20.82%
66.25M
12.64%
73.61M
11.12%
77.96M
5.90%
81.26M
4.24%
87.56M
7.75%
92.40M
5.53%
weighted average shs out dil
33.85M
-
40.03M
18.25%
42.29M
5.66%
48.70M
15.15%
58.82M
20.78%
66.25M
12.64%
73.61M
11.12%
77.96M
5.90%
81.26M
4.24%
87.56M
7.75%
92.40M
5.53%
eps
-3.31
-
-3.39
2.42%
-5.20
53.39%
-5.49
5.58%
-0.86
84.34%
-5.46
534.88%
-9.71
77.84%
-7.11
26.78%
-5.15
27.57%
-8.03
55.92%
-5.80
27.77%
epsdiluted
-3.31
-
-3.39
2.42%
-5.20
53.39%
-5.49
5.58%
-0.86
84.34%
-5.46
534.88%
-9.71
77.84%
-7.11
26.78%
-5.15
27.57%
-8.03
55.92%
-5.80
27.77%

All numbers in (except ratios and percentages)